Special Issue Title:

Advances in Ovarian Cancer Research

Deadline for manuscript submissions: 31 July 2025

Print Special Issue Flyer (4)

Special Issue Editor

  • Guest Editor

    Basel Refky, MDE-MailWebsite

    Surgical oncology department, Oncology Centre Mansoura University (OCMU), Mansoura, Egypt

    Interests: Gynaecological Oncology; Surgical Oncology; Ovarian Cancer

Special Issue Information

Dear Colleagues,

Ovarian cancer remains a significant and challenging health issue worldwide, posing a considerable burden on women's health. It is the eighth most common cancer among women and the fifth leading cause of cancer-related deaths in women. The high mortality rate is often attributed to the late-stage diagnosis and limited treatment options available. Over the years, scientific research has been dedicated to understanding the complexities of ovarian cancer, aiming to improve early detection methods, develop targeted therapies, and enhance patient outcomes.

Additionally, efforts to test the relatives of ovarian cancer patients for gene mutations are crucial. Identifying these mutations early can help in taking preventive measures and tailoring more effective treatment plans, addressing the global variation in ovarian cancer incidence and outcomes.

This special issue on Advances in Ovarian Cancer Research holds immense significance in the field of oncology and women's health. It serves as a platform to consolidate the latest findings, breakthroughs, and innovations in ovarian cancer research. By illuminating the current landscape of research efforts, this special issue aims to raise awareness about the challenges faced in combating ovarian cancer and inspire collaboration among researchers, clinicians, and policymakers. Furthermore, it provides insights into emerging trends, novel therapeutic approaches, and promising biomarkers that have the potential to revolutionize ovarian cancer management.

Recent advancements in ovarian cancer research have shown promising developments. One such advancement is fluorescence-guided surgery, which uses fluorescent drugs to highlight cancerous tissues, enabling more precise tumor removal. This technique significantly improves the outcomes of cytoreductive surgery, a standard treatment approach for reducing tumor burden before chemotherapy.

The primary goal of this special issue is to present a comprehensive overview of the recent advancements in ovarian cancer research. Through a collection of original research articles, review papers, and expert commentaries, this special issue aims to address key research gaps, identify unmet clinical needs, and propose innovative strategies for advancing the field. Additionally, by encouraging interdisciplinary discussions and knowledge exchange, the special issue seeks to foster a collaborative environment that accelerates the translation of scientific discoveries into clinical practice. Ultimately, the goal is to drive progress towards personalized treatment approaches, improved survival rates, and ultimately, a cure for ovarian cancer.

In conclusion, the Special Issue on Advances in Ovarian Cancer Research offers a unique opportunity to highlight the collective efforts of the scientific community towards combating this challenging disease. By highlighting cuttingedge research and pioneering initiatives, this special issue aims to inspire transformative changes in the field of ovarian cancer research and pave the way for a brighter future for women affected by this devastating illness.

Dr. Basel Refky

Guest Editor


Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time